Lpl Financial LLC Seres Therapeutics, Inc. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 122,225 shares of MCRB stock, worth $94,113. This represents 0.0% of its overall portfolio holdings.

Number of Shares

122,225

Previous 140,625 13.08%

Holding current value

$94,113

Previous $101,000 14.85%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$0.7 - $1.48 $12,880 - $27,232	-18,400 Reduced 13.08%	122,225 $116,000
Q2 2024 Aug 07, 2024	BUY	$0.56 - $1.19 $6,076 - $12,911	10,850 Added 8.36%	140,625 $101,000
Q1 2024 May 10, 2024	BUY	$0.75 - $1.56 $10,683 - $22,222	14,245 Added 12.33%	129,775 $99,000
Q4 2023 Feb 14, 2024	SELL	$0.93 - $2.15 $7,830 - $18,103	-8,420 Reduced 6.79%	115,530 $161,000
Q3 2023 Nov 13, 2023	BUY	$2.33 - $5.07 $20,718 - $45,082	8,892 Added 7.73%	123,950 $295,000
Q2 2023 Jul 31, 2023	BUY	$4.67 - $6.55 $90,541 - $126,991	19,388 Added 20.27%	115,058 $551,000
Q1 2023 May 10, 2023	BUY	$4.95 - $6.09 $13,706 - $16,863	2,769 Added 2.98%	95,670 $542,000
Q4 2022 Feb 07, 2023	SELL	$5.09 - $9.05 $41,748 - $74,228	-8,202 Reduced 8.11%	92,901 $520,000
Q3 2022 Nov 14, 2022	SELL	$3.5 - $7.2 $7,350 - $15,120	-2,100 Reduced 2.03%	101,103 $649,000
Q2 2022 Aug 12, 2022	BUY	$2.7 - $7.62 $143,353 - $404,576	53,094 Added 105.96%	103,203 $354,000
Q1 2022 May 16, 2022	BUY	$6.3 - $8.84 $26,510 - $37,198	4,208 Added 9.17%	50,109 $357,000
Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $23,345 - $44,325	3,878 Added 9.23%	45,901 $382,000
Q3 2021 Nov 15, 2021	SELL	$5.46 - $22.6 $123,827 - $512,545	-22,679 Reduced 35.05%	42,023 $292,000
Q2 2021 Aug 13, 2021	SELL	$18.46 - $24.36 $3,045 - $4,019	-165 Reduced 0.25%	64,702 $1.54 Million
Q1 2021 May 14, 2021	BUY	$17.66 - $28.92 $121,995 - $199,779	6,908 Added 11.92%	64,867 $1.34 Million
Q4 2020 Feb 12, 2021	SELL	$23.25 - $37.73 $26,458 - $42,936	-1,138 Reduced 1.93%	57,959 $1.42 Million
Q3 2020 Nov 09, 2020	SELL	$3.74 - $28.74 $57,648 - $442,998	-15,414 Reduced 20.69%	59,097 $1.67 Million
Q2 2020 Aug 13, 2020	SELL	$3.04 - $6.2 $5,523 - $11,265	-1,817 Reduced 2.38%	74,511 $355,000
Q1 2020 May 14, 2020	BUY	$2.64 - $3.82 $28,710 - $41,542	10,875 Added 16.61%	76,328 $272,000
Q4 2019 Feb 14, 2020	BUY	$2.99 - $4.42 $8,081 - $11,947	2,703 Added 4.31%	65,453 $226,000
Q3 2019 Nov 13, 2019	BUY	$2.29 - $4.16 $22,098 - $40,144	9,650 Added 18.17%	62,750 $252,000
Q2 2019 Aug 09, 2019	BUY	$2.28 - $7.35 $90,629 - $292,162	39,750 Added 297.75%	53,100 $171,000
Q1 2019 May 08, 2019	BUY	$4.83 - $7.21 $64,480 - $96,253	13,350 New	13,350 $92,000

Others Institutions Holding MCRB

# of Institutions

Shares Held

40.5M

Call Options Held

304K

Put Options Held

471K

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $95.5M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Seres Therapeutics, Inc. Transaction History